Who Exports Antidandruff from India — 4 Suppliers Behind a $9.3K Market
India's antidandruff export market is supplied by 4 active exporters who collectively shipped $9.3K across 12 shipments. EDGES MEDICARE PRIVATE LIMITED leads with a 30.9% market share, followed by DR.JRK'S RESEARCH AND PHARMACEUTICALS PRIVATE LIMI. The top 5 suppliers together control 47.6% of total export value, reflecting a moderately competitive market structure.

Top Antidandruff Exporters from India — Ranked by Export Value
EDGES MEDICARE PRIVATE LIMITED is the leading antidandruff exporter from India, holding a 30.9% share of the $9.3K market across 12 shipments from 4 exporters. The top 5 suppliers — EDGES MEDICARE PRIVATE LIMITED, DR.JRK'S RESEARCH AND PHARMACEUTICALS PRIVATE LIMI — collectively control 47.6% of total export value, indicating a competitive market. Individual shares are: EDGES MEDICARE PRIVATE LIMITED (30.9%), DR.JRK'S RESEARCH AND PHARMACEUTICALS PRIVATE LIMI (16.7%).
Top Antidandruff Exporters from India
Ranked by export value · 4 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | EDGES MEDICARE PRIVATE LIMITED | $2.9K | 1 | 30.9% |
| 2 | DR.JRK'S RESEARCH AND PHARMACEUTICALS PRIVATE LIMI SIDDHA SYSTEM-DANO ANTIDANDRUFF OIL 100MSIDDHA SYSTEM-DANO ANTIDANDRUFF OIL 20ML | $1.6K | 1 | 16.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Antidandruff exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Edges Medicare Private Limited | Not Listed | Yes | Yes | Not verified | Edges Medicare Pvt. Ltd. holds ISO 13485 and CE certifications, indicating compl |
| DR. JRK's Research and Pharmaceuticals Private Limited | Not Listed | Yes | Not Listed | Not verified | DR. JRK's Research and Pharmaceuticals Pvt. Ltd. is a GMP and ISO certified comp |
TransData Nexus reviewed the regulatory standing of 2 leading Antidandruff exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Antidandruff sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs). The city's well-established infrastructure and supportive regulatory environment have attracted numerous pharmaceutical companies, making it a strategic location for sourcing APIs essential for antidandruff formulations.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Major companies like Zydus Lifesciences, headquartered in Ahmedabad, have contributed to the region's prominence in producing finished pharmaceutical products. This area offers a robust ecosystem for developing and manufacturing antidandruff formulations, leveraging its extensive experience in the pharmaceutical sector.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. With access to major ports like Nhava Sheva (Jawaharlal Nehru Port), this region facilitates efficient international distribution. The presence of numerous pharmaceutical companies and export-oriented units enhances its role in the global supply chain for antidandruff products.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, partly due to favorable tax incentives. The region hosts over 3,000 factories, including facilities of major pharmaceutical companies. Its strategic location and cost advantages make it an attractive area for producing antidandruff products.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supplier concentration, consider engaging with multiple suppliers across different regions, including Hyderabad, Ahmedabad-Vadodara, Mumbai-Thane-Raigad, and Baddi-Nalagarh.
- Leverage Export Hubs: Utilize the export capabilities of the Mumbai-Thane-Raigad region to enhance international distribution efficiency for antidandruff products.
- Explore Tax Incentives: Assess the benefits of manufacturing in tax incentive zones like Baddi-Nalagarh to optimize production costs.
- Monitor Regulatory Compliance: Ensure all suppliers adhere to the regulatory standards set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and compliance.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Antidandruff exporters from India
Akums Drugs and Pharmaceuticals — Akums Drugs and Pharmaceuticals expands manufacturing capacity post-IPO
Following its successful IPO in August 2024, Akums Drugs and Pharmaceuticals announced plans to expand its manufacturing facilities to meet growing demand. The company aims to enhance its production capabilities across various pharmaceutical segments.
Impact: This expansion could lead to increased production of antidandruff products, potentially affecting market dynamics.
Emnar Pharma Private Limited — Emnar Pharma receives FDA Establishment Inspection Report
Emnar Pharma Private Limited received the FDA’s Establishment Inspection Report (EIR), reinforcing its commitment to high standards in pharmaceutical manufacturing and regulatory compliance.
Impact: This approval may enhance Emnar Pharma's credibility, potentially increasing its role in the antidandruff product supply chain.
Syngene International — Syngene partners with Amgen for advanced R&D center
Syngene International established a long-term collaboration with Amgen, resulting in the dedicated Syngene Amgen Research & Development Center (SARC) in Bengaluru. This partnership aims to provide end-to-end support across discovery, development, and manufacturing.
Impact: The collaboration may lead to innovations in pharmaceutical formulations, including antidandruff products, influencing market offerings.
Common Questions — Antidandruff Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which antidandruff supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, EDGES MEDICARE PRIVATE LIMITED leads with 4 recorded shipments worth $2.9K. DR.JRK'S RESEARCH AND PHARMACEUTICALS PRIVATE LIMI (3 shipments) and (0 shipments) are also established high-volume exporters.
Q How many antidandruff manufacturers are there in India?
India has 4 active antidandruff exporters with a combined export market of $9.3K across 12 shipments to 4 countries. The top 5 suppliers hold 47.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for antidandruff from India?
Average FOB unit price: $1.86 per unit, ranging from $0.49 to $2.93. Average shipment value: $777.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 4 verified Indian exporters of Antidandruff ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 12 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 4 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
4 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists